Pathfinder Cell Therapy, Inc.

PFND · OTC
Analyze with AI
9/30/2015
6/30/2015
3/31/2015
12/31/2014
Assets
Cash & Equivalents$4$0$21$26
Short-Term Investments$0$0$0$0
Receivables$0$0$0$0
Inventory$0$0$0$0
Other Curr. Assets$5$18$33$47
Total Curr. Assets$9$18$54$73
Property Plant & Equip (Net)$0$0$0$0
Goodwill$0$0$0$0
Intangibles$30$31$32$33
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$0$0$0$0
Total NC Assets$30$31$32$33
Other Assets$0$0$0$0
Total Assets$39$49$86$106
Liabilities
Payables$326$323$279$229
Short-Term Debt$5,413$5,231$5,154$4,983
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$1,030$936$872$837
Total Curr. Liab.$6,769$6,490$6,305$6,049
LT Debt$0$0$0$0
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$0
Total NC Liab.$0$0$0$0
Other Liabilities$0$0$0$0
Cap. Leases$0$0$0$0
Total Liabilities$6,769$6,490$6,305$6,049
Equity
Pref Stock$0$0$0$0
Common Stock$667$667$667$667
Retained Earnings-$19,227-$18,938-$18,716-$18,440
AOCI$0$0$0$0
Other Equity$11,830$11,830$11,830$11,830
Total Equity-$6,730-$6,441-$6,219-$5,943
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$39$49$86$106
Net Debt$5,409$5,231$5,133$4,957
Pathfinder Cell Therapy, Inc. (PFND) Financial Statements & Key Stats | AlphaPilot